"IMPORT FOR EXPORT" PROVISIONS OF EXPORT LAW MAY BE EXPANDED TO INCLUDE UNAPPROVED FINISHED DEVICES; "TRANSSHIPMENT" OF EXPORTS ALSO MAY BE ADDRESSED
This article was originally published in The Gray Sheet
Congress may expand the "import for export" provisions of "The FDA Export Reform and Enhancement Act of 1996" to allow importation into the U.S. of unapproved finished devices intended for subsequent export, congressional staffers told attendees at a June 27 Food and Drug Law Institute conference in Washington, D.C. The current provisions, which were signed into law April 26, allow manufacturers to import unapproved "components" for assembly of finished devices meant for export.
You may also be interested in...
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.